Elimination of Dengue Virus with Antiviral Compound and Appropriate Technology
Downloads
Infection with the dengue virus by the Aedes aegypti mosquito vector is in the form of dengue hemorrhagic fever (DHF), which can cause a decrease in platelets and even death. The parasitic drug niclosamide, which is effective against dengue virus serotype 2 (DENV-2) is used to prevent further dengue virus infection. Many tests were carried out using inhibitors such as doxorubicin (SA-17), glycoside inhibitors in the form of deocynojirimycin (DNJ) and castanospermine (CSP), carbohydrate-binding agents (CBA), and the use of heparan sulfate aimed at inhibition of the adsorption process and replication process, as well as improper protein folding to prevent the conformation of virus merger. The elimination process can also be carried out using antiviral compounds found in the leaves of Psidium guajava and Carica papaya, which have inhibitory activities of 92.6% and 89.5%, respectively; propyl gallate, with a percent inhibition of dengue virus envelope protein serotype 2 of 53-9.85%; isobutyl gallate, with CC50 values of 167.19 g/mL and an inhibitory value (IC50) of 4.45; Cissampelos Pariera Linn methanol extract, with progressive inhibition as the Cipa extract concentration increased with an IC50 value of 6.1μg/ml Preventive methods are also carried out in several ways, namely by utilizing hydrophobic liquid in the form of silicone oil (low-viscosity polydimethylsiloxane, or L-PDMS), the use of eave tubes in home tubes inserted with insecticides, and utilizing ultrasound with a frequency of 100 kHz and 90 dB to repel mosquitoes carrying dengue virus vectors.
P. M. Armstrong and R. Rico-Hesse, "Efficiency of dengue serotype 2 virus strains to infect and disseminate in Aedes aegypti," Am J Trop Med Hyg, vol. 68, no. 5, pp. 539-44, May 2003, doi: 10.4269/ajtmh.2003.68.539.
M. Arisanti and N. H. Suryaningtyas, "Kejadian demam berdarah dengue (DBD) di Indonesia tahun 2010-2019," Spirakel, vol. 13, no. 1, pp. 34-41, 2021.
R. Kemenkes, "Modul pengendalian demam berdarah dengue," Jakarta. Kementerian Kesehatan Republik Indonesia Direktorat Jendral Pengendalian dan Penyehatan Lingkungan, 2011.
F. Ali, A. Chorsiya, V. Anjum, S. Khasimbi, and A. Ali, "A systematic review on phytochemicals for the treatment of dengue," Phytother Res, vol. 35, no. 4, pp. 1782-1816, Apr 2021, doi: 10.1002/ptr.6917.
C. Nasriyah, "Efektivitas Cairan Kristaloid Dengan Cairan Koloid Pada Dengue Hemorrhage Fever," Prosiding Diseminasi Hasil Penelitian Dosen Program Studi Keperawatan dan Farmasi Volume 3 Nomor 2 Bulan September Tahun 2021, vol. 3, no. 2, 2021.
S. Idrees and U. A. Ashfaq, "RNAi: antiviral therapy against dengue virus," Asian Pac J Trop Biomed, vol. 3, no. 3, pp. 232-6, Mar 2013, doi: 10.1016/S2221-1691(13)60057-X.
N. Nanaware, A. Banerjee, S. Mullick Bagchi, P. Bagchi, and A. Mukherjee, "Dengue Virus Infection: A Tale of Viral Exploitations and Host Responses," Viruses, vol. 13, no. 10, p. 1967, Sep 30 2021, doi: 10.3390/v13101967.
J. C. Kao et al., "The antiparasitic drug niclosamide inhibits dengue virus infection by interfering with endosomal acidification independent of mTOR," PLoS Negl Trop Dis, vol. 12, no. 8, p. e0006715, Aug 2018, doi: 10.1371/journal.pntd.0006715.
A. Jurgeit, R. McDowell, S. Moese, E. Meldrum, R. Schwendener, and U. F. Greber, "Niclosamide Is a Proton Carrier and Targets Acidic Endosomes with Broad Antiviral Effects," (in English), Plos Pathogens, vol. 8, no. 10, p. e1002976, Oct 2012, doi: ARTN e100297610.1371/journal.ppat.1002976.
B. D. Fonseca et al., "Structure-activity analysis of niclosamide reveals potential role for cytoplasmic pH in control of mammalian target of rapamycin complex 1 (mTORC1) signaling," J Biol Chem, vol. 287, no. 21, pp. 17530-17545, May 18 2012, doi: 10.1074/jbc.M112.359638.
M. R. Ho et al., "Blockade of dengue virus infection and viral cytotoxicity in neuronal cells in vitro and in vivo by targeting endocytic pathways," Sci Rep, vol. 7, no. 1, p. 6910, Jul 31 2017, doi: 10.1038/s41598-017-07023-z.
K. H. Lin, A. Ali, L. Rusere, D. I. Soumana, N. Kurt Yilmaz, and C. A. Schiffer, "Dengue Virus NS2B/NS3 Protease Inhibitors Exploiting the Prime Side," J Virol, vol. 91, no. 10, pp. 10.1128/jvi. 00045-17, May 15 2017, doi: 10.1128/JVI.00045-17.
Z. Li et al., "Existing drugs as broad-spectrum and potent inhibitors for Zika virus by targeting NS2B-NS3 interaction," (in English), Cell Research, vol. 27, no. 8, pp. 1046-1064, Aug 2017, doi: 10.1038/cr.2017.88.
M. M. F. Alen and D. Schols, "Dengue Virus Entry as Target for Antiviral Therapy," (in English), Journal of Tropical Medicine, vol. 2012, no. 1, p. 628475, 2012, doi: Artn 62847510.1155/2012/628475.
T. F. Senes-Lopes et al., "Genotoxicity of Turnera subulata and Spondias mombin x Spondias tuberosa Extracts from Brazilian Caatinga Biome," J Med Food, vol. 21, no. 4, pp. 372-379, Apr 2018, doi: 10.1089/jmf.2017.0041.
A. C. Sayce, J. L. Miller, and N. Zitzmann, "Targeting a host process as an antiviral approach against dengue virus," (in English), Trends in Microbiology, vol. 18, no. 7, pp. 323-330, Jul 2010, doi: 10.1016/j.tim.2010.04.003.
K. Whitby et al., "Castanospermine, a potent inhibitor of dengue virus infection in vitro and in vivo," J Virol, vol. 79, no. 14, pp. 8698-706, Jul 2005, doi: 10.1128/JVI.79.14.8698-8706.2005.
C. Vichasilp et al., "Optimization of 1-deoxynojirimycin extraction from mulberry leaves by using response surface methodology," Biosci Biotechnol Biochem, vol. 73, no. 12, pp. 2684-9, Dec 2009, doi: 10.1271/bbb.90543.
G. Brahmachari, Discovery and development of therapeutics from natural products against neglected tropical diseases. Elsevier, 2019.
P. Y. Lozach et al., "Dendritic cell-specific intercellular adhesion molecule 3-grabbing non-integrin (DC-SIGN)-mediated enhancement of dengue virus infection is independent of DC-SIGN internalization signals," (in English), Journal of Biological Chemistry, vol. 280, no. 25, pp. 23698-23708, Jun 24 2005, doi: 10.1074/jbc.M504337200.
W. K. Lai et al., "Expression of DC-SIGN and DC-SIGNR on human sinusoidal endothelium: a role for capturing hepatitis C virus particles," Am J Pathol, vol. 169, no. 1, pp. 200-8, Jul 2006, doi: 10.2353/ajpath.2006.051191.
E. Lee, M. Pavy, N. Young, C. Freeman, and M. Lobigs, "Antiviral effect of the heparan sulfate mimetic, PI-88, against dengue and encephalitic flaviviruses," Antiviral Res, vol. 69, no. 1, pp. 31-8, Jan 2006, doi: 10.1016/j.antiviral.2005.08.006.
P. Olczyk, L. Mencner, and K. Komosinska-Vassev, "Diverse Roles of Heparan Sulfate and Heparin in Wound Repair," Biomed Res Int, vol. 2015, no. 1, p. 549417, 2015, doi: 10.1155/2015/549417.
L. Saptawati et al., "In vitro study of eight Indonesian plants extracts as anti Dengue virus," Health Science Journal of Indonesia, vol. 8, no. 1, pp. 12-18, 2017.
K. Zandi, B. T. Teoh, S. S. Sam, P. F. Wong, M. R. Mustafa, and S. Abubakar, "Antiviral activity of four types of bioflavonoid against dengue virus type-2," Virol J, vol. 8, p. 560, Dec 28 2011, doi: 10.1186/1743-422X-8-560.
F. Yunita, E. Hanani, and J. Kristianto, "The effect of Carica papaya L. leaves extract capsules on platelets count and hematocrit level in dengue fever patient," 2012.
J. Aziz, N. L. Abu Kassim, N. H. Abu Kasim, N. Haque, and M. T. Rahman, "Carica papaya induces in vitro thrombopoietic cytokines secretion by mesenchymal stem cells and haematopoietic cells," BMC Complement Altern Med, vol. 15, p. 215, Jul 8 2015, doi: 10.1186/s12906-015-0749-6.
A. Suganthi and T. Ravi, "Estimation of Anti-Dengue Phytochemical Markers Gallic Acid, Rutin and Quercetin in Methanolic Extract of Euphorbia Hirta (L.) and Tawa-Tawa Capsule Formulation by Validated RP-HPLC Method," Chem. Methodologies, vol. 3, no. 1, pp. 43-54, 2018.
B. Dewi, M. Angelina, F. Nuwwaaridya, H. Desti, and T. Sudiro, "Antiviral Activity of Isobutyl Gallate to Dengue Virus Serotype 2 In Vitro," in IOP Conference Series: Earth and Environmental Science, 2019, vol. 251: IOP Publishing, p. 012018.
K. A. A. Kusuma, H. Desti, and B. E. Dewi, "In vitro and in silico approach to evaluate propyl gallate as antiviral drug to dengue virus through viral attachment inhibition," Teikyo Medical Journal, vol. 47, no. 6, 2022.
P. L. Wei, C. Y. Huang, and Y. J. Chang, "Propyl gallate inhibits hepatocellular carcinoma cell growth through the induction of ROS and the activation of autophagy," (in English), Plos One, vol. 14, no. 1, p. e0210513, Jan 17 2019, doi: ARTN e021051310.1371/journal.pone.0210513.
A. Ahmad, I. Wahid, M. Massi, R. Arfah, and H. Karim, "Anti-dengue potential of bioactive protein from exophytic bacteria that are symbiotic with brown algae Sargassum sp," in Journal of Physics: Conference Series, 2019, vol. 1341, no. 3: IOP Publishing, p. 032012.
A. Ahmad, N. Asmi, H. Karim, M. N. Massi, I. Wahid, and A. Sugrani, "Characterization of anti-dengue and cytotoxic activity of protein hydrolysates from the exophytic bacteria of brown algae Sargassum sp," Journal of Applied Pharmaceutical Science, vol. 11, no. 2, pp. 039-045, 2021.
E. Teerasak, P. Thongararm, S. Roytrakul, L. Meesuk, and P. Chumnanpuen, "Prediction of anticancer peptides against MCF-7 breast cancer cells from the peptidomes of Achatina fulica mucus fractions," Computational and structural biotechnology journal, vol. 14, pp. 49-57, 2016.
R. Sood et al., "Linn: Natural Source of Potent Antiviral Activity against All Four Dengue Virus Serotypes," (in English), Plos Neglected Tropical Diseases, vol. 9, no. 12, p. e0004255, Dec 2015, doi: ARTN e000425510.1371/journal.pntd.0004255.
B. Widom, "Capillarity and wetting phenomena: drops, bubbles, pearls, waves," Physics Today, vol. 57, no. 12, pp. 66-67, 2004.
L. S. Nerio, J. Olivero-Verbel, and E. Stashenko, "Repellent activity of essential oils: a review," Bioresour Technol, vol. 101, no. 1, pp. 372-8, Jan 2010, doi: 10.1016/j.biortech.2009.07.048.
E. J. Dennis, O. V. Goldman, and L. B. Vosshall, "Mosquitoes Use Their Legs to Sense DEET on Contact," (in English), Current Biology, vol. 29, no. 9, pp. 1551-+, May 6 2019, doi: 10.1016/j.cub.2019.04.004.
H. Iikura, H. Takizawa, S. Ozawa, T. Nakagawa, Y. Matsui, and H. Nambu, "Mosquito repellence induced by tarsal contact with hydrophobic liquids," Sci Rep, vol. 10, no. 1, p. 14480, Sep 2 2020, doi: 10.1038/s41598-020-71406-y.
L. S. Tusting et al., "The evidence for improving housing to reduce malaria: a systematic review and meta-analysis," Malar J, vol. 14, p. 209, Jun 9 2015, doi: 10.1186/s12936-015-0724-1.
J. Snetselaar et al., "Eave tubes for malaria control in Africa: prototyping and evaluation against Anopheles gambiae ss and Anopheles arabiensis under semi-field conditions in western Kenya," Malaria journal, vol. 16, pp. 1-11, 2017.
E. D. Sternberg et al., "Eave tubes for malaria control in Africa: initial development and semi-field evaluations in Tanzania," Malar J, vol. 15, no. 1, p. 447, Sep 1 2016, doi: 10.1186/s12936-016-1499-8.
N. Golding et al., "Integrating vector control across diseases," BMC Med, vol. 13, p. 249, Oct 1 2015, doi: 10.1186/s12916-015-0491-4.
M. Tavares et al., "Trends in insect repellent formulations: A review," Int J Pharm, vol. 539, no. 1-2, pp. 190-209, Mar 25 2018, doi: 10.1016/j.ijpharm.2018.01.046.
D. I. Kim, R. Ilyasov, U. Yunusbaev, S. H. Lee, and H. W. Kwon, "Behavioral and molecular responses of to ultrasound," (in English), Journal of Asia-Pacific Entomology, vol. 24, no. 1, pp. 429-435, Apr 2021, doi: 10.1016/j.aspen.2020.12.016.
G. Menda et al., "The Long and Short of Hearing in the Mosquito Aedes aegypti," Curr Biol, vol. 29, no. 4, pp. 709-714 e4, Feb 18 2019, doi: 10.1016/j.cub.2019.01.026.
C. J. McMeniman, R. A. Corfas, B. J. Matthews, S. A. Ritchie, and L. B. Vosshall, "Multimodal integration of carbon dioxide and other sensory cues drives mosquito attraction to humans," Cell, vol. 156, no. 5, pp. 1060-71, Feb 27 2014, doi: 10.1016/j.cell.2013.12.044.
Copyright (c) 2023 Journal of Bio-molecule Research And Engineering
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
COPYRIGHT NOTICE
1. By submitting the article toJournal of Bio-Molecule Research and Engineering [JBIOME], the author has agreed to transfer some of the copyrights to the publisher of the research chemistry journal, Universitas Airlangga, indicated in the Copyright Transfer Agreement.
2. Authors still retain significant rights to use and share their own published articles for non-commercial purposes subject to Creative Commons Attribution-NonComercial-ShareALike 4.0 International License
3. All publications (printed/electronic) are open access for educational purposes, research, library, and other non-commercial purposes. Besides the purposes mentioned above, the editorial board is not responsible for copyright violations.
